Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
1.200
+0.010 (0.84%)
At close: Apr 2, 2026, 4:00 PM EDT
1.180
-0.020 (-1.67%)
After-hours: Apr 2, 2026, 7:55 PM EDT
Bionano Genomics Employees
As of December 31, 2025, Bionano Genomics had 97 total employees, including 95 full-time and 2 part-time employees. The number of employees decreased by 3 or -3.00% compared to the previous year.
Employees
97
Change (1Y)
-3
Growth (1Y)
-3.00%
Revenue / Employee
$293,897
Profits / Employee
-$272,113
Market Cap
13.31M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 97 | -3 | -3.00% | 95 | 2 |
| Dec 31, 2024 | 100 | -244 | -70.93% | 98 | 2 |
| Dec 31, 2023 | 344 | -61 | -15.06% | 344 | 0 |
| Sep 30, 2023 | 388 | -17 | -4.20% | 388 | 0 |
| Dec 31, 2022 | 405 | 106 | 35.45% | 405 | 0 |
| Dec 31, 2021 | 299 | 152 | 103.40% | 299 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Harvard Bioscience | 339 |
| Jin Medical International | 273 |
| Retractable Technologies | 227 |
| Femasys | 71 |
| Ekso Bionics Holdings | 55 |
| Nephros | 36 |
| NEXGEL | 19 |
| Milestone Scientific | 17 |
BNGO News
- 1 day ago - Bionano Announces Publication from Johns Hopkins and MD Anderson Showing that OGM can Outperform Traditional Methods in Analysis of Multiple Myeloma - GlobeNewsWire
- 11 days ago - Bionano Genomics Stock Soars As Efficiency Gains Meet Growth Story - Benzinga
- 11 days ago - Bionano Reports Fourth Quarter and Full-Year 2025 Results and Provides Revenue Outlook for 2026 - GlobeNewsWire
- 15 days ago - Bionano Genomics Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Benzinga
- 25 days ago - Bionano to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call Webcast on March 23, 2026 - GlobeNewsWire
- 5 weeks ago - Bionano Symposium 2026 Concluded with 9 Speakers Describing the Breadth of Bionano Solutions and Their Potential for Use on a Large Scale - GlobeNewsWire
- 5 weeks ago - 10 Presentations on Day 3 of Bionano Symposium 2026 Showcase OGM's Utility in Unraveling the Complex Puzzles of Constitutional Genetic Disorders - GlobeNewsWire
- 5 weeks ago - 11 Presentations on Day 2 of Bionano Symposium 2026 Showcase Expanding Impact of Optical Genome Mapping Across Oncology and Cell & Gene Therapy - GlobeNewsWire